DoorDash, Inc. vs Regeneron Pharmaceuticals, Inc.
Market cap comparison over time
DoorDash, Inc.
$79.1B
Rank #193
Regeneron Pharmaceuticals, Inc.
$79.7B
Rank #191
Market Cap Over Time
Key Moments
- Regeneron Pharmaceuticals, Inc. overtook DoorDash, Inc. by 2021
- DoorDash, Inc. overtook Regeneron Pharmaceuticals, Inc. by 2025
- Regeneron Pharmaceuticals, Inc. overtook DoorDash, Inc. by 2026
Year-by-Year Comparison
| Year | DoorDash, Inc. | Regeneron Pharmaceuticals, Inc. | Leader |
|---|---|---|---|
| 2026 | $79.1B | $79.7B | Regeneron Pharmaceuticals, Inc. |
| 2025 | $93.2B | $79.3B | DoorDash, Inc. |
| 2024 | $69.0B | $72.8B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $40.7B | $89.7B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $20.1B | $73.7B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $61.2B | $64.5B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $58.7B | $49.4B | DoorDash, Inc. |